Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 4/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.33 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 3/20 | 0.32 |
| ▸ | PDE2A | O00408 | 2/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16440009 | 0.83 | — | — | |
| SCHEMBL9828749 | 0.77 | ALDH1A1 (0.37) | TSHRKIF11ALDH1A1PKM | |
| SCHEMBL146433 | 0.74 | PDE2A (0.37) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL149760 | 0.74 | TSHR (0.37) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL148163 | 0.73 | TSHR (0.35) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL9725680 | 0.73 | TSHR (0.35) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL95846 | 0.73 | KIF11 (0.36) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL4852287 | 0.73 | TSHR (0.45) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL3081819 | 0.73 | MGLL (0.41) | TSHRMAPK1KIF11PTPN5NOS3 | |
| SCHEMBL101521 | 0.73 | PDE2A (0.36) | TSHRMAPK1KIF11PTPN5NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | claimed |
| EP-2532663-A1 | Naphthalenecarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2012-12-12 | — | — | EP | claimed |
| US-20240108006-A1 | PESTICIDALLY ACTIVE HETEROAROMATIC COMPOUNDS | SYNGENTA CROP PROTECTION AG (CH) | 2024-04-04 | — | — | US | disclosed |
| WO-2024022910-A1 | 1-[1-[2-(PYRIMIDIN-4-YL)-1,2,4-TRIAZOL-3-YL]ETHYL]-3-[2,4-DICHLORO-5-PHENYL]UREA DERIVATIVES AND SIMILAR COMPOUNDS AS PESTICIDES | SYNGENTA CROP PROTECTION AG (CH) | 2024-02-01 | — | — | WO | disclosed |
| CN-117412961-A | Pesticidally active heteroaromatic compounds | 先正达农作物保护股份公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-4281185-A2 | PESTICIDALLY ACTIVE HETEROAROMATIC COMPOUNDS | Syngenta Crop Protection AG (CH) | 2023-11-29 | — | — | EP | disclosed |
| US-9783523-B2 | N-acylimino heterocyclic compounds | BASF SE (DE) | 2017-10-10 | — | — | US | disclosed |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2017-06-22 | — | — | US | disclosed |
| US-9512354-B2 | Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics | BASF SE (DE) | 2016-12-06 | — | — | US | disclosed |
| US-20160297793-A1 | N-ACYLIMINO HETEROCYCLIC COMPOUNDS | BASF SE (DE) | 2016-10-13 | — | — | US | disclosed |
| EP-2532663-B1 | Naphthalenetetracarboxylic acid derivatives and their use as semiconductors | BASF SE (DE) | 2016-03-16 | — | — | EP | disclosed |
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | BASF SE (DE) | 2011-03-24 | — | — | US | disclosed |
| EP-2297274-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2011-03-23 | — | — | EP | disclosed |
| WO-2009147237-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2009-12-10 | — | — | WO | disclosed |
| US-20090301552-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2009-12-10 | — | — | US | disclosed |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | BASF AKTIENGESELLSCHAFT (DE) | 2009-07-02 | — | — | US | disclosed |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | BASF SE (DE) | 2008-12-04 | — | — | US | disclosed |
| EP-1780211-A2 | Vanilloid receptor ligands and their use in treatments | Amgen Inc. (US) | 2007-05-02 | — | — | EP | disclosed |
| EP-1775295-A1 | Vanilloid receptor ligands and their use in treatments | Amgen Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110203649-A1 | USE OF INDANTHRENE COMPOUNDS IN ORGANIC PHOTOVOLTAICS | ICMT, EPCAM, INF2 | TSHR 4614/4885MAPK1 4322/4885KIF11 3359/4885 |
| US-20090301552-A1 | CHLORINATED NAPHTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO4C1, SLCO2B1 | TSHR 1100/4885MAPK1 4361/4885KIF11 555/4885 |
| US-20110068328-A1 | HALOGEN-CONTAINING PERYLENETETRACARBOXYLIC ACID DERIVATIVES AND THE USE THEREOF | NR0B1, NR0B2, RXRB | TSHR 357/4885MAPK1 1374/4885KIF11 1732/4885 |
| US-20170174676-A1 | CHLORINATED NAPTHALENETETRACARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND USE THEREOF IN ORGANIC ELECTRONICS | SLCO2A1, SLCO2B1, SLC43A3 | TSHR 1739/4885MAPK1 4301/4885KIF11 1256/4885 |
| US-20080300405-A1 | Naphthalenetetracarboxylic Aicd Derivatives and their Use as Semiconductors | ADSL, ALAD, EED | TSHR 4522/4885MAPK1 4790/4885KIF11 1865/4885 |
| US-20240108006-A1 | PESTICIDALLY ACTIVE HETEROAROMATIC COMPOUNDS | DDT, ACHE, GSTO1 | TSHR 2069/4885MAPK1 1760/4885KIF11 3883/4885 |
| US-20090166614-A1 | FLUORINATED RYLENETETRACARBOXYLIC ACID DERIVATIVES AND USE THEREOF | FXR2, FXR1, FTO | TSHR 810/4885MAPK1 2994/4885KIF11 1415/4885 |
| US-20160297793-A1 | N-ACYLIMINO HETEROCYCLIC COMPOUNDS | CBR3, C5, ALOX5 | TSHR 2179/4885MAPK1 3729/4885KIF11 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.